These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1177660)

  • 1. [Diagnostic significance of serum hemopexin in patients with malignant melanoma].
    Popović S; Roguljić A; Nola P; Maricić Z
    Lijec Vjesn; 1975; 97(4):241-4. PubMed ID: 1177660
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIA, a novel serum marker for progression of malignant melanoma.
    Bosserhoff AK; Lederer M; Kaufmann M; Hein R; Stolz W; Apfel R; Bogdahn U; Buettner R
    Anticancer Res; 1999; 19(4A):2691-3. PubMed ID: 10470221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma.
    Altomonte M; Colizzi F; Esposito G; Maio M
    N Engl J Med; 1992 Sep; 327(13):959. PubMed ID: 1355268
    [No Abstract]   [Full Text] [Related]  

  • 5. Parathyroid hormone-related protein in patients with malignant melanoma.
    Elias AN; Pandian MR; Jacowatz J
    Arch Dermatol; 1992 Feb; 128(2):278-9. PubMed ID: 1739318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Copper content and the ceruloplasmin activity in the blood in melanoma of the skin].
    Sergeev SI; Kochetkova MK; Romanova OA
    Vopr Onkol; 1978; 24(10):61-5. PubMed ID: 716320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sialic acid in malignant melanoma patients: an ROC curve analysis.
    Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
    Anticancer Res; 1999; 19(4C):3619-22. PubMed ID: 10629661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum selenium levels in patients with malignant melanoma.
    Reinhold U; Biltz H; Bayer W; Schmidt KH
    Acta Derm Venereol; 1989; 69(2):132-6. PubMed ID: 2564230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum sialic acid bound to lipoproteins. Its contribution to the diagnosis and follow-up of melanoma].
    Sánchez Conejo-Mir J; Sotillo Gago I; Camacho F; Iglesias Huertas R
    Med Cutan Ibero Lat Am; 1990; 18(4):219-23. PubMed ID: 2077306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediagnostic serum levels of 1,25-dihydroxyvitamin D and malignant melanoma.
    Cornwell ML; Comstock GW; Holick MF; Bush TL
    Photodermatol Photoimmunol Photomed; 1992 Jun; 9(3):109-12. PubMed ID: 1300138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of alpha-fetoprotein in the serum of patients with leukemia and malignant melanoma.
    Mihalev A; Tzingilev D; Sirakov LM
    Neoplasma; 1976; 23(1):103-7. PubMed ID: 58389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decreased blood histamine levels in malignant melanoma].
    Kölmel KF
    Dermatol Monatsschr; 1987; 173(10):577-84. PubMed ID: 3428460
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative investigations of the pregnancy associated alpha 2-glycoprotein (PAG) in malignant melanoma (author's transl)].
    Göring HD; Bundschuh G; Schubert H; Lukowsky A; Knopf B; Lübbe D; Wohlrab W
    Dermatol Monatsschr; 1981 Apr; 167(4):217-23. PubMed ID: 7262378
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.
    Hofmann MA; Gussmann F; Fritsche A; Biesold S; Schicke B; Küchler I; Voit C; Trefzer U
    Melanoma Res; 2009 Feb; 19(1):17-23. PubMed ID: 19104451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
    Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
    Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular staging in stage II and III melanoma patients.
    Margolin K
    Curr Oncol Rep; 2005 Sep; 7(5):376. PubMed ID: 16091199
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum zinc levels are increased in melanoma patients.
    Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
    Melanoma Res; 1998 Jun; 8(3):273-7. PubMed ID: 9664150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.